TXMD
TherapeuticsMD, Inc.
Customer concentration
— top 3 customers 100% of revenue
3 customers — 100% of revenue (the three months ended March 31, 2026)
“For the three months ended March 31, 2026, 100% of license revenue related to Mayne Pharma, Theramex and Knight.”
Company with tickers: TXMD
CIK
25743
CUSIP
88338N206
Shares Outstanding
11,574,362
Website
https://www.therapeuticsmd.com
13F Activity (30d)
4 filings
3 filers
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
46/100
Short interest 0.4% of shares — P31
Days to cover 3.3 — P56
Short-volume trend -0.8% — P49
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-05-29). Equal-weight mean of the available factors.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-05-29 | 51,412 | 53,083 | -1,671 | 3.27 |
| 2026-05-15 | 53,083 | 56,765 | -3,682 | 2.33 |
| 2026-04-30 | 56,765 | 52,193 | +4,572 | 2.72 |
| 2026-04-15 | 52,193 | 48,285 | +3,908 | 2.13 |
| 2026-03-31 | 48,285 | 47,542 | +743 | 2.25 |
Showing 1–5 of 5 settlements